vs
JBG SMITH Properties（JBGS）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
JBG SMITH Properties的季度营收约是RIGEL PHARMACEUTICALS INC的1.8倍（$127.6M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -35.7%，领先419.7%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -2.5%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -6.3%）
JBG SMITH Properties是一家总部位于马里兰州贝塞斯达的上市房地产投资信托公司，专注于持有并运营房地产资产，是美国商业地产领域的专业运营机构，面向市场提供多元化的不动产投资与管理服务。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
JBGS vs RIGL — 直观对比
营收规模更大
JBGS
是对方的1.8倍
$69.8M
营收增速更快
RIGL
高出23.7%
-2.5%
净利率更高
RIGL
高出419.7%
-35.7%
两年增速更快
RIGL
近两年复合增速
-6.3%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $127.6M | $69.8M |
| 净利润 | $-45.5M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -47.5% | 33.2% |
| 净利率 | -35.7% | 384.0% |
| 营收同比 | -2.5% | 21.2% |
| 净利润同比 | 24.0% | 1769.2% |
| 每股收益（稀释后） | $-0.76 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收JBGSRIGL
| Q4 25 | $127.6M | $69.8M | ||
| Q3 25 | $123.9M | $69.5M | ||
| Q2 25 | $126.5M | $101.7M | ||
| Q1 25 | $120.7M | $53.3M | ||
| Q4 24 | $130.8M | $57.6M | ||
| Q3 24 | $136.0M | $55.3M | ||
| Q2 24 | $135.3M | $36.8M | ||
| Q1 24 | $145.2M | $29.5M |
净利润JBGSRIGL
| Q4 25 | $-45.5M | $268.1M | ||
| Q3 25 | $-28.6M | $27.9M | ||
| Q2 25 | $-19.2M | $59.6M | ||
| Q1 25 | $-45.7M | $11.4M | ||
| Q4 24 | $-59.9M | $14.3M | ||
| Q3 24 | $-27.0M | $12.4M | ||
| Q2 24 | $-24.4M | $-1.0M | ||
| Q1 24 | $-32.3M | $-8.2M |
毛利率JBGSRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率JBGSRIGL
| Q4 25 | -47.5% | 33.2% | ||
| Q3 25 | -27.5% | 40.9% | ||
| Q2 25 | -18.4% | 60.1% | ||
| Q1 25 | -44.7% | 23.9% | ||
| Q4 24 | -53.6% | 28.9% | ||
| Q3 24 | -22.4% | 25.4% | ||
| Q2 24 | -24.3% | 1.2% | ||
| Q1 24 | -30.1% | -23.6% |
净利率JBGSRIGL
| Q4 25 | -35.7% | 384.0% | ||
| Q3 25 | -23.1% | 40.2% | ||
| Q2 25 | -15.2% | 58.6% | ||
| Q1 25 | -37.9% | 21.5% | ||
| Q4 24 | -45.8% | 24.9% | ||
| Q3 24 | -19.8% | 22.5% | ||
| Q2 24 | -18.0% | -2.8% | ||
| Q1 24 | -22.2% | -27.9% |
每股收益（稀释后）JBGSRIGL
| Q4 25 | $-0.76 | $14.11 | ||
| Q3 25 | $-0.48 | $1.46 | ||
| Q2 25 | $-0.29 | $3.28 | ||
| Q1 25 | $-0.56 | $0.63 | ||
| Q4 24 | $-0.70 | $0.82 | ||
| Q3 24 | $-0.32 | $0.70 | ||
| Q2 24 | $-0.27 | $-0.06 | ||
| Q1 24 | $-0.36 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $75.3M | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $1.2B | $391.5M |
| 总资产 | $4.4B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资JBGSRIGL
| Q4 25 | $75.3M | $155.0M | ||
| Q3 25 | $64.4M | $137.1M | ||
| Q2 25 | $61.4M | $108.4M | ||
| Q1 25 | $81.3M | $77.1M | ||
| Q4 24 | $145.8M | $77.3M | ||
| Q3 24 | $137.0M | $61.1M | ||
| Q2 24 | $163.5M | $49.1M | ||
| Q1 24 | $220.5M | $49.5M |
总债务JBGSRIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益JBGSRIGL
| Q4 25 | $1.2B | $391.5M | ||
| Q3 25 | $1.2B | $117.6M | ||
| Q2 25 | $1.3B | $81.9M | ||
| Q1 25 | $1.6B | $18.6M | ||
| Q4 24 | $1.8B | $3.3M | ||
| Q3 24 | $1.9B | $-14.6M | ||
| Q2 24 | $2.0B | $-29.9M | ||
| Q1 24 | $2.1B | $-31.7M |
总资产JBGSRIGL
| Q4 25 | $4.4B | $513.6M | ||
| Q3 25 | $4.4B | $242.5M | ||
| Q2 25 | $4.5B | $206.7M | ||
| Q1 25 | $4.7B | $176.0M | ||
| Q4 24 | $5.0B | $164.0M | ||
| Q3 24 | $5.2B | $139.4M | ||
| Q2 24 | $5.3B | $128.4M | ||
| Q1 24 | $5.4B | $126.5M |
负债/权益比JBGSRIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $73.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流JBGSRIGL
| Q4 25 | $73.3M | $22.0M | ||
| Q3 25 | $8.9M | $24.0M | ||
| Q2 25 | $18.8M | $30.5M | ||
| Q1 25 | $12.9M | $-893.0K | ||
| Q4 24 | $129.4M | $14.5M | ||
| Q3 24 | $26.4M | $21.7M | ||
| Q2 24 | $23.8M | $302.0K | ||
| Q1 24 | $37.0M | $-5.0M |
现金转化率JBGSRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
